RefleXion Medical is an external-beam theranostic oncology company that pioneers in using its breakthrough SCINTIX® technology. This biology-guided radiotherapy detects and responds to signals emitted by cancer cells, delivering immediate treatment for tumors, particularly in the lung or bone. SCINTIX therapy is unique in that it uses a platform that combines PET-CT and radiotherapy to effectively target tumors, even those in motion, without severely affecting surrounding tissues. This innovative approach opens up new treatment avenues for metastatic and primary cancers, offering hope to those previously ineligible for radiotherapy. The company continues to advance its multi-target treatment capabilities, working closely with clinicians and cancer centers to integrate this groundbreaking technology into comprehensive cancer care programs. RefleXion Medical is committed to improving patient outcomes by enhancing the effectiveness of cancer treatment modalities.